Moreover, to investigate the potential synergistic enhancement of anti‐PD‐L1 efficacy through combination treatment with NAT10 knockdown, we also monitored tumor growth after anti‐PD‐L1 antibody treatment in different groups in the model. Here, CD274 is linked to neoplasm.